EUPV2025


A
AFZAL FAZIL United Kingdom MHRA - Senior Medical Assessor
ARIZMENDI VELEZ CRISTINA Spain AEMPS - Chief of Cosmetovigilance and Safety of Cosmetic Products
AYOUB AYMAN United Kingdom GSK - Vice President Safety Evaluation and Risk Management
B
BARAC KLAUDIJA MARIJANOVIC Croatia TEVA - Sr. Director, Head of Teva Periodic reports and risk management Centre
BATE ANDREW GSK - VP, Head of Safety Innovation & Analytics
BILUSIC VUNDAC VJERA PRIMEVIGILANCE LTD - Senior Director, Medical Writing
BLACKBURN ANITA United Kingdom FORTREA - Labeling Lead
BOTSIS TAXIARCHIS United States of America JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE - USA - Associate Professor
BOURJI CHERGUI HANAE France BECTON AND DICKINSON - Regulatory Affairs Senior Specialist
C
CALISSANO MATTIA United Kingdom SSI Strategy - VP, Medical
CASELLI ANTONELLA Italy AIFA - Senior Clinical & Safety Assessor
CASTIGLIONE GIAN NICOLA Italy SIMeF - Pharmacovigilance Senior Consultant, Secretary and Member of Management Board of SIMeF ETS, Master of Labor. Head of Global Pharmacovigilance, QPPV
CIUCA MIRCEA Switzerland Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
D
D'ANTUONO MARGHERITA Italy PIRAMAL CRITICAL CARE - EU-UK QPPV
DE GREGORIO FABIO United Kingdom SHIONOGI EUROPE - Vice President, Head of Safety
DREYER NANCY United States of America UNIV OF NORTH CAROLINA, CHAPEL HILL - Chief Scientific Officer retired IQVIA and Professor
F
FRETTA ANTONELLA Italy PFIZER - Senior Director
FURLAN GIOVANNI Germany SANDOZ - Head Medical Safety Operations
G
GLASER MICHAEL United Kingdom GSK - Safety Innovation Technology Director
GRISONI ILARIA Italy JAZZ PHARMACEUTICALS - Exec. Dir., Head of EU/International PV & Office of QPPV, EEA QPPV
H
HAGUINET FRANÇOIS France GSK - Associate Director for Safety and Quantitative Innovation
K
KORENJAK MARKO Slovenia European Liver Patients’ Association (ELPA); former PRAC member - President
KURZINGER MARIE-LAURE France SANOFI - Associate VP, Head of Pharmacoepidemiology - General Medicines, Pharmacovigilance and Patient Safety
L
LITTLEBURY RORY United Kingdom GSK - Head of PV System Oversight and QPPV Office
P
PARIENTE ANTOINE France UNIVERITY OF BORDEAUX - Professor of Clinical Pharmacology and Pharmacoepidemiology, Head of the Public Health Research Department

Messenger